Shopping Cart
Remove All
  • TargetMol
    Your shopping cart is currently empty

Edasalonexent

Copy Product Info
😃Good
TargetMol
Catalog No. T15198Cas No. 1204317-86-1
Alias CAT-1004

Edasalonexent (CAT-1004) is an orally available NF-κB inhibitor designed to improve Duchenne muscular dystrophy.

Edasalonexent

Edasalonexent

Copy Product Info
😃Good
TargetMol
Purity: 99.13%
Catalog No. T15198Alias CAT-1004Cas No. 1204317-86-1
Edasalonexent (CAT-1004) is an orally available NF-κB inhibitor designed to improve Duchenne muscular dystrophy.
Pack SizePriceUSA WarehouseGlobal WarehouseQuantity
1 mg$60-In Stock
5 mg$148-In Stock
10 mg$238-In Stock
25 mg$427-In Stock
50 mg$672-In Stock
100 mg$886-In Stock
1 mL x 10 mM (in DMSO)$160-In Stock
Add to Cart
Add to Quotation
In Stock Estimated shipping dateUSA Warehouse[1-2 days] Global Warehouse[5-7 days]
This molecule is a custom-made product. TargetMol has an excellent synthesis team with the experience and capability to provide you with cost-effective products.If you have any questions, please feel free to contact us. We are committed to serving you wholeheartedly.
All TargetMol products are for research purposes only and cannot be used for human consumption. We do not provide products or services to individuals. Please comply with the intended use and do not use TargetMol products for any other purpose.
Questions
TargetMol
View More

Batch Information

Select Batch
Purity:99.13%
Appearance:Oil
Color:Yellow
Contact us for more batch information

Resource Download

Product Introduction

Bioactivity
Description
Edasalonexent (CAT-1004) is an orally available NF-κB inhibitor designed to improve Duchenne muscular dystrophy.
In vitro
Edasalonexent effectively inhibits the pathogenic NF-κB subunit p65/RelA in vitro[3].
In vivo
In vivo, Edasalonexent effectively improves the phenotype of mdx mice in terms of activity, muscle mass and function, injury, inflammation, fibrosis, and cardiac pathology associated with voluntary wheel running[3].
SynonymsCAT-1004
Chemical Properties
Molecular Weight490.68
FormulaC31H42N2O3
Cas No.1204317-86-1
SmilesCC\C=C/C\C=C/C\C=C/C\C=C/C\C=C/C\C=C/CCC(=O)NCCNC(=O)c1ccccc1O
Relative Density.1.031 g/cm3 (Predicted)
Storage & Solubility Information
StoragePure form: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature.
Solubility Information
DMSO: 80 mg/mL (163.04 mM), Sonication is recommended.
In Vivo Formulation
10% DMSO+40% PEG300+5% Tween 80+45% Saline: 2.5 mg/mL (5.09 mM), Sonication is recommended.
Please add the solvents sequentially, clarifying the solution as much as possible before adding the next one. Dissolve by heating and/or sonication if necessary. Working solution is recommended to be prepared and used immediately. The formulation provided above is for reference purposes only. In vivo formulations may vary and should be modified based on specific experimental conditions.
Solution Preparation Table
DMSO
1mg5mg10mg50mg
1 mM2.0380 mL10.1899 mL20.3799 mL101.8994 mL
5 mM0.4076 mL2.0380 mL4.0760 mL20.3799 mL
10 mM0.2038 mL1.0190 mL2.0380 mL10.1899 mL
20 mM0.1019 mL0.5095 mL1.0190 mL5.0950 mL
50 mM0.0408 mL0.2038 mL0.4076 mL2.0380 mL
100 mM0.0204 mL0.1019 mL0.2038 mL1.0190 mL

Calculator

  • Molarity Calculator
  • Dilution Calculator
  • Reconstitution Calculator
  • Molecular Weight Calculator

In Vivo Formulation Calculator (Clear solution)

Please enter your animal experiment information in the following box and click Calculate to obtain the stock solution preparation method and in vivo formula preparation method:
TargetMol | Animal experiments For example, if the intended dosage is 10 mg/kg for animals weighing 20 g , with a dosing volume of 100 μL per animal, TargetMol | Animal experiments and a total of 10 animals are to be administered, using a formulation of TargetMol | reagent 10% DMSO+ 40% PEG300+ 5% Tween 80+ 45% Saline/PBS/ddH2O , the resulting working solution concentration would be 2 mg/mL.
Stock Solution Preparation:

Dissolve 2 mg of the compound in 100 μL DMSOTargetMol | reagent to obtain a stock solution at a concentration of 20 mg/mL . If the required concentration exceeds the compound's known solubility, please contact us for technical support before proceeding.

Preparation of the In Vivo Formulation:

1) Add 100 μL of the DMSOTargetMol | reagent stock solution to 400 μL PEG300TargetMol | reagent and mix thoroughly until the solution becomes clear.

2) Add 50 μL Tween 80 and mix well until fully clarified.

3) Add 450 μL Saline,PBS or ddH2OTargetMol | reagent and mix thoroughly until a homogeneous solution is obtained.

This example is provided solely to demonstrate the use of the In Vivo Formulation Calculator and does not constitute a recommended formulation for any specific compound. Please select an appropriate dissolution and formulation strategy based on your experimental model and route of administration.
All co-solvents required for this protocol, includingDMSO, PEG300/PEG400, Tween 80, SBE-β-CD, and Corn oil, are available for purchase on the TargetMol website.
1 Enter information below:
mg/kg
g
μL
2 Enter the in vivo formulation:
% DMSO
%
% Tween 80
% Saline/PBS/ddH2O

Dose Conversion

You can also refer to dose conversion for different animals. More Dose Conversion

Tech Support

Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc

Keywords

Related Tags: buy Edasalonexent | purchase Edasalonexent | Edasalonexent cost | order Edasalonexent | Edasalonexent chemical structure | Edasalonexent in vivo | Edasalonexent in vitro | Edasalonexent formula | Edasalonexent molecular weight